| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
4e-12 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
4e-12 |
| mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
6e-10 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
9e-10 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
2e-09 |
| mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
1e-08 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
4e-08 |
| mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-08 |
| mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
1e-07 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-07 |